GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $208,000 | -23.0% | 5,831 | -20.4% | 0.00% | -33.3% |
| Q4 2020 | $270,000 | -97.4% | 7,329 | -97.4% | 0.00% | -97.9% |
| Q3 2020 | $10,585,000 | -6.1% | 281,221 | +1.8% | 0.14% | -13.3% |
| Q2 2020 | $11,273,000 | +58.9% | 276,369 | +47.6% | 0.16% | +38.7% |
| Q1 2020 | $7,096,000 | +2650.4% | 187,282 | +3308.8% | 0.12% | +3866.7% |
| Q4 2019 | $258,000 | +10.3% | 5,494 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $234,000 | +6.4% | 5,494 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $220,000 | -4.3% | 5,494 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $230,000 | +9.5% | 5,494 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $210,000 | -5.0% | 5,494 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $221,000 | 0.0% | 5,494 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $221,000 | +2.8% | 5,494 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $215,000 | +10.3% | 5,494 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $195,000 | -12.6% | 5,494 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $223,000 | -5.9% | 5,494 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $237,000 | – | 5,494 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |